Predicting regulatory mutations and their target genes by new computational integrative analysis: A study of

Junbai Wang1, Mingyi Yang2, Omer Ali3

  • 1Department of Clinical Molecular Biology (EpiGen), Akershus University Hospital and University of Oslo, Lørenskog, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Campus AHUS/Oslo, Norway.

Insights

Identifying cancer-driving mutations in non-coding DNA is challenging. This study introduces a mutation block (MB) approach and new Python tools to analyze clusters of SNPs, revealing novel disease-associated genes in follicular lymphoma.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Mutations in DNA regulatory regions are key drivers of cancer and complex diseases.
  • These mutations impact gene expression via DNA-protein binding and epigenetic modifications like DNA methylation.
  • Identifying mutation hotspots in non-coding DNA linked to gene regulation and disease remains difficult.

Purpose of the Study:

  • To develop and validate a novel mutation block (MB)-based approach for assessing the collective impact of SNP clusters on gene expression and DNA methylation.
  • To identify long-distance target genes of functional MBs using a new permutation-based algorithm.
  • To introduce two Python packages, DMR-analysis and DDS-analysis, for integrated multi-omics data analysis.

Main Methods:

  • Developed a mutation block (MB) approach to evaluate the combined effect of single nucleotide polymorphisms (SNPs) on transcription factor-DNA binding, differential gene expression (DEG), and DNA methylation.
  • Utilized a novel permutation-based algorithm to identify long-distance target genes by correlating DNA methylation in regulatory regions with target gene expression.
  • Created two Python packages: DMR-analysis for detecting differential methylation regions (DMRs) and DDS-analysis for integrating DMR, DEG, and SNP data.

Main Results:

  • Validated the MB-based approach and Python tools in follicular lymphoma (FL) cohorts.
  • Successfully identified known functional MBs and their target genes (BCL2, BCL6) in FL.
  • Discovered novel FL-associated genes, CDCA4 and JAG2, significantly correlated with target gene expression and nearby DNA methylation.

Conclusions:

  • The proposed computational integrative analysis of multi-omics data effectively identifies functional mutation blocks and their target genes.
  • The novel MB-based approach and associated Python tools offer a promising strategy for discovering regulatory mutations in cancer and other complex diseases.
  • The identified novel genes (CDCA4, JAG2) may play roles in FL development, warranting further investigation.